Postantibiotic effects of gatifloxacin against gram-positive and - negative organisms

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2574-2575

  Pankuch, G A ^a   Jacobs, M R ^b   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN;

ARTICLE; BACTERICIDAL ACTIVITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032842787     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2574     Document Type: Article

References (17)

1. Bauernfeind, A. 1997. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother. 40:639-651.
2. Cars, O., and I. Odenholt-Tornqvist. 1993. The postantibiotic subMIC effect in vitro and in vivo. J. Antimicrob. Chemother. 31:159-166.
3. Craig, W. 1993. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens. Eur. J. Clin. Microbiol. Infect. Dis. 12(Suppl. 1):6-8.
4. Craig, W. A., and S. Gudmundsson. 1996. Postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams and Wilkins Co., Baltimore, Md.
5. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 1998. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob. Agents Chemother. 42:2459-2462.
6. Hoellman, D. B., G. Lin, M. R. Jacobs, and P. C. Appelbaum. 1999. Antipneumococcal activity of gatifloxacin compared to other quinolone and nonquinolone agents. J. Antimicrob. Chemother. 43:645-649.
7. Hosaka, M., S. Kinoshita, A. Tovama, M. Otsuki, and T. Nishino. 1995. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J. Antimicrob. Chemother. 36:293-301.
8. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 36:2108-2117.
9. Kato, N., H. Kato, K. Tanaka-Bandoh, K. Watanabe, and K. Ueno. 1997 Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria. J. Antimicrob. Chemother. 40:631-637.
10. MacKenzie, F. M., and I. M. Gould. 1993. The post-antibiotic effect. J. Antimicrob. Chemother. 32:519-537.
11. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), 1995. Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
12. Nakashima, M., T. Uematsu, K. Kosuge, H. Kusajima, T. Ooie, V. Masuda, R. Ishida, and H. Uchida. 1995. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob. Agents Chemother. 39:2635-2640.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Odenholt-Tornqvist, I. 1993. Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem. J. Antimicrob. Chemother. 31:881-892.
15. Odenholt-Tomqvist, I, E. Löwdin, and O. Cars. 1992. Postantibiotic subMIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
16. Wakabayashi, E., and S. Mitsuhashi. 1994. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 38:594-601.
17. Wise, R., N. P. Brenwald, J. M. Andrews, and F. Boswell. 1997. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. J. Antimicrob. Chemother. 39:447-452.